Dissecting the molecular landscape of resistance to ROS1 TKIs

At ELCC 2023, Marc Terrones from the University of Antwerp presented his research on dissecting the molecular landscape of resistance to ROS1 TKIs using improved pre-clinical models for NSCLC. His work sheds light on the mechanisms behind resistance to these drugs and may help guide the development of more effective treatment strategies for NSCLC patients.